Insider · CIK 0001230232

DOUMANI ROY

Reports to the SEC for 2 companies · SANTA MONICA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001230232

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-10-03	Kite Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−151K sh	$180.00	−$27.1M	1,807
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$173.11	−$5.19M	0
2017-10-03	Kite Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−25.1K sh	$180.00	−$4.51M	0
2017-10-03	Kite Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,807 sh	—	—	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,810 sh	$88.79	−$782K	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	$129.13	−$904K	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$120.77	−$1.21M	0
2017-06-20	Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+8,810 sh	—	—	8,810
2017-06-20	Kite Pharma, Inc.A Award	Director	AAward	+2,410 sh	—	—	152,427
2017-06-08	Kite Pharma, Inc.S Sale	Director	SSale	−5,000 sh	$84.53	−$423K	150,017
2017-06-07	Kite Pharma, Inc.S Sale	Director	SSale	−10K sh	$84.46	−$845K	155,017
2017-03-01	Kite Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	75,065
2017-03-01	Kite Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.35	+$67.5K	75,065
2017-03-01	Kite Pharma, Inc.S Sale	Director	SSale	−2,800 sh	$76.77	−$215K	25,065
2017-03-01	Kite Pharma, Inc.S Sale	Director	SSale	−6,000 sh	$77.03	−$462K	115,017
2017-03-01	Kite Pharma, Inc.S Sale	Director	SSale	−10K sh	$72.27	−$723K	121,017
2016-06-06	Kite Pharma, Inc.S Sale	Director	SSale	−5,000 sh	$58.25	−$291K	136,017
2016-06-06	Kite Pharma, Inc.S Sale	Director	SSale	−5,000 sh	$57.56	−$288K	131,017
2016-06-06	Kite Pharma, Inc.S Sale	Director	SSale	−4,000 sh	$58.38	−$234K	27,865
2016-06-01	Kite Pharma, Inc.A Award	Director	AAward	+1,950 sh	—	—	141,017
2016-06-01	Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2015-06-09	Kite Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2004-06-01	CTI MOLECULAR IMAGING INCPhantom Stock (Deferred Stock Units)A Award	Director	AAward	+3,859 sh	—	—	8,859

Recent filings

Accepted (ET)
Oct 54
DOUMANI ROY0001209191-17-056234
SEC(opens sec.gov)
Jun 224
Kite Pharma, Inc.0001209191-17-041307
SEC(opens sec.gov)
Jun 94
Kite Pharma, Inc.0001209191-17-039021
SEC(opens sec.gov)
Mar 24
Kite Pharma, Inc.0000899243-17-005889
SEC(opens sec.gov)
Jun 84
Kite Pharma, Inc.0001209191-16-126659
SEC(opens sec.gov)
Jun 34
Kite Pharma, Inc.0001209191-16-125842
SEC(opens sec.gov)

Companies

Address

C/O KITE PHARMA, INC. 2225 SANTA MONICA AVENUE

SANTA MONICA, CA, 90404